We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.10 | 9.70 | 10.50 | 10.10 | 10.10 | 10.10 | 177,070 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.83 | 93.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/9/2018 10:25 | that was not the question that you have answered, I asked you why are you here ? you have been saying the same for years but you still remain | inanaco | |
04/9/2018 10:22 | Yes, the Science looks promising but the rest of it is a pile of Sh%£$. the fact they keep missing their timescales is costing us all a lot of money. If they had kept to their timescales the Shareprice would be a lot higher and we would not been raising funds at 10 & 12p. As I have said before this does not affect the BOD as they just very conveniently adjust their options but they have cost all of us a lot of money and as for your forecasts of £6 and £8 do you think those targets get nearer or further away with dilution at 10 & 12p. | panama7 | |
04/9/2018 10:14 | Panama why are you here then ? even Lozdob thinks the science is Imaginary | inanaco | |
04/9/2018 10:05 | Wigwammer no point in highlighting what the BOD have said and what their timelines are. They have never once stuck to them and they are completely pointless. They are only there to continually mislead and con Investors. The only timescales they have managed to adhere to are the ones that include funding and the issuing of extravagant pay rises | panama7 | |
04/9/2018 10:00 | Update, April 2018. First part, fully funded."The Company intends to commence enrolment of Stage III/IV metastatic melanoma patients to the study in Q4 2018, led by principal investigator Dr Keith Flaherty. Following which, the Phase 2 trial will be completed in two parts. The Directors believe that the first part of the Phase 2 trial will be completed in H1 2019 and the second part will be completed in H1 2020." | wigwammer | |
04/9/2018 09:56 | Many thanks for ALL your posts, goosed. Interesting that many here are particularly grateful for a negative one. Perhaps, far from being an alternative view, a heightened concern about funding is really a little consensual :) | wigwammer | |
04/9/2018 09:33 | Thanks Goosed. | tosh123 | |
04/9/2018 08:37 | "Final Results time fast approaching."....Ind . Whereas, it's good to see someone {else}'taking note' of this FACT, that "Outlook" may, at first glance appear 'promising',BUT, that WAS the "Outlook" ONE YEAR AGO... What has changed ??? Just for BALANCE = *WE ALL* might remind ourselves - SCLP have 'Raised FUNDS' {diluted} around springtime, in EACH of the past three years, with a falling 'offer price'. As opposed to the RISING imaginary trHYPE 'value' of £1 a share - £6 a share - £8+ a share. . Where would SCLP be without those ANNUAL {diluting} FUND RAISINGS... The last of which, 'the trHYPER-in-Chief' was urging = was "NOT an ISSUE here" ??? . Certain folks get very 'upset / petulant' when their 'Rose-tinted specs' are taken away. I would not include a normally much calmer goosed there,*WE ALL* know who they are. | the real lozan | |
04/9/2018 08:19 | Thanks goosed. Emphasises how important funding is to the whole trial scenario. | gazza | |
04/9/2018 07:51 | Final Results time fast approaching. A paragraph from last years concluding forecast : "Outlook The Company has recently published robust survival data for SCIB1 showing median observation times in excess of five years in resected patients. These results, together with a successful IND submission to the FDA, will put the Company in a good position to embark upon a US Phase 2 study of SCIB1 in combination with a checkpoint inhibitor. The commencement of such a study is dependent upon the timing and outcome of the IND submission plus the Company's ability to raise sufficient funds to enable the study to be fully funded." | gooosed | |
04/9/2018 07:51 | Anyway, back to SCLP. It would appear the predicted lull has well and truly taken hold. I wonder if there is a storm on the horizon to get us out of the doldrums? | gazza | |
04/9/2018 07:44 | Just to make it clear:I AM following my own advice. | gazza | |
04/9/2018 07:42 | TF, well I suspect your opinion doesn't carry much weight.You have chosen not to acknowledge the problem here, you have instead chosen to attack individuals rather than contribute to the debate. Finally, try and work out the significance (or difference) of "the OTHER thread" and "HERE". | gazza | |
04/9/2018 03:35 | Gazza / Ruck - your posts yesterday - a very poor defence of your hypocrisy IMO. Coming back to your 751 on the other thread - ''If someone inadvertently posts the latter here, (i.e. mindless name-calling and one-upmanship), perhaps we could respectfully remind them and NOT respond in a like manner.'' As my 17487, maybe follow your own advice ? | torquayfan | |
03/9/2018 23:25 | Counsel. Not council. If you aren?t sure then use a different word. | wigwammer | |
03/9/2018 23:25 | Given SCLP rather uniquely has an entire advfn board dedicated to these ?alternative? views, and the point that there has evidently been far more sellers than buyers over the last 3 years, I am left wondering how ?alternative? these views really are :) | wigwammer | |
03/9/2018 20:38 | *ViewS*. Not *View*. If you aren’t sure then use a different word. | the real lozan | |
03/9/2018 20:33 | Counsel. Not council. If you aren't sure then use a different word. | wigwammer | |
03/9/2018 19:15 | The Astooties just accept the alternative view has been more profitable than the view widely held ny members of the MFFF. Der Leader on that site being the biggest Goon of all | drdobson1 | |
03/9/2018 18:59 | Given SCLP rather uniquely has an entire advfn board dedicated to this "alternative" view, and the point that there has evidently been far more sellers than buyers over the last 3 years, I am left wondering how "alternative" this view really is :) | wigwammer | |
03/9/2018 18:00 | Tosh absolutely nail on Head. I have 9/9 and all aimed at INE person. You expertly point out why this us the case with the vast majority on here. If the said individual stayed away we can all CONcentrste on balanced informative posts which discuss both SCience and Commercial u like the MFFF which seems to extinguish any alternative vuews | drdobson1 | |
03/9/2018 16:31 | Gazza .... laid the wreath but was not involved | inanaco | |
03/9/2018 16:28 | Yes. Determining instigator quite important. Quite selective on the day too. I wonder how Thursday looks.. | wigwammer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions